{"data":{"Year":[2020,2020],"COMMENT_OBS":["Obs_Value = 0;  Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested.","Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested."],"SDG Series":["Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested [3.d.2]","Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested [3.d.2]"],"Observation-level footnotes":["Obs_Value = 0;  Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested.","Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested."],"Value":[0,25]},"edges":{"From":["COMMENT_OBS","SDG Series"],"To":["SDG Series","Observation-level footnotes"]}}